Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Clinical trial NCT05832229 · RECRUITING

Trial details

NCT number: NCT05832229
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cirrhosis Cirrhosis, Liver Cirrhosis Early Cirrhosis Due to Hepatitis B Cirrhosis Advanced Cirrhosis Infectious Cirrhosis Alcoholic Cirrhosis Due to Hepatitis C

Start date: 2023-12-07
Primary completion: 2029-08-31
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.